Disclosure Panels Details Page

Breast Cancer Risk Reduction Panel - Disclosures as of 08/12/2011

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Deborah Armstrong MD AstraZeneca Pharmaceuticals LP
Clovis Oncology
Eisai Inc.
Pfizer Inc.
Syndax
AbbVie, Inc. None None NA
Banu Arun MD AstraZeneca Pharmaceuticals LP
Invitae : research paid to the institution
None None None NA
Mary Anne Bergman None None None None NA
Therese Bevers MD Preferred Medicine
Toray International
None None None NA
Robert Carlson MD None None None None NA -
Graham Colditz MD, DrPH, FAFPHM Centine Corp , St Louis
Grailbio
None None None NA
Kenneth Cowan MD, PhD Merck & Co., Inc. None None None NA -
Mary Daly MD, PhD, FACP None None None None NA
Lauren Gallagher None None None None None
Judy Garber MD, MPH Ambry Genetics
AstraZeneca Pharmaceuticals LP
Invitae Genetics
Myriad Genetic Laboratories, Inc.
Adrienne Helis Melvin Research Foundation
Aleta Bio-Therapeutics
American Association for Cancer Research
American Society of Clinical Oncology
Diane Helis Henry Medical Research Foudation
GTx, Inc.
GV20 Therapeutics
H3 Biomedicine, Inc.
Helix Genetics
James P. Wilmot Foundation Inc.
Konica Minolta
Kronos Bio
Novartis Pharmaceuticals Corporation
Susan G. Komen for the Cure
None Breast Cancer Research Foundation NA
Mary Gemignani MD None None None None NA -
William Gradishar MD Daiichi- Sankyo Co.
Genentech, Inc.
Immunomedics, Inc.
Seattle Genetics, Inc.
AstraZeneca Pharmaceuticals LP
Merck & Co., Inc.
Pfizer Inc.
None None NA
Kristina Gregory MSN, RN, OCN None None None None NA -
Larissa Korde MD, MPH None Amgen Inc. None None None -
Helen Krontiras MD None None None None None
Swati Kulkarni MD None None None None NA
Rashmi Kumar PhD None None None None NA
Christine Laronga MD, FACS None None None None NA
Loretta Loftus MD, MBA None Greenberg, Traurig Law Firm Expert Witness
Tyme Development Committee
United States Department of Justice Expert Witness
None Amgen Inc. |Eli Lilly and Company|Gilead Sciences, Inc.|Johnson & Johnson|Pfizer Inc. NA
Deborah MacDonald PhD, APNG None None None None NA -
Martin Mahoney MD, PhD None Merck & Co., Inc.
Pfizer Inc.
Merck & Co., Inc.
Pfizer Inc.
sanofi-aventis U.S.
None NA
Joan McClure MS None None None None NA
Sofia Merajver MD, PhD None None None Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. NA
Ingrid Meszoely MD None None None None NA -
Lisa Newman MD, MPH None None None None NA
Frances Pritchard MD None None None None NA -
Victoria Seewaldt MD None None None None None -
Rena Sellin MD None None None None NA
Charles Shapiro MD None None None None NA
John Ward MD None None None None NA